Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Common Stock | Options Exercise | +748 | +2.43% | 31.5K | Mar 10, 2024 | Direct | F1, F2 | ||
transaction | GILD | Common Stock | Options Exercise | +1.93K | +6.14% | 33.4K | Mar 10, 2024 | Direct | F1 | ||
transaction | GILD | Common Stock | Tax liability | -$59.3K | -790 | -2.36% | $75.12 | 32.6K | Mar 10, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Restricted Stock Unit | Options Exercise | -748 | -4.53% | 15.8K | Mar 10, 2024 | Common Stock | 748 | Direct | F1, F3 | |||
transaction | GILD | Restricted Stock Unit | Options Exercise | -1.93K | -12.26% | 13.8K | Mar 10, 2024 | Common Stock | 1.93K | Direct | F1, F4 | |||
transaction | GILD | Non-qualified Stock Option (Right to Buy) | Award | $0 | +13.7K | $0.00 | 13.7K | Mar 10, 2024 | Common Stock | 13.7K | $75.12 | Direct | F5 | |
transaction | GILD | Restricted Stock Unit | Award | +4.83K | +34.87% | 18.7K | Mar 10, 2024 | Common Stock | 4.83K | Direct | F1, F4 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
F2 | Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. |
F3 | The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. |
F4 | The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
F5 | The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |